Kidney-limited TMA is common in patients with complement dysregulation

Kidney Int. 2024 Sep;106(3):536-537. doi: 10.1016/j.kint.2024.06.009.

¹ Expert Center for Immune-mediated Kidney Diseases and Vasculitis, Maastricht University Medical Center, Maastricht, the Netherlands; Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands.
² Expert Center for Immune-mediated Kidney Diseases and Vasculitis, Maastricht University Medical Center, Maastricht, the Netherlands; Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands. Electronic address: [email protected].

No abstract available

Publication types